Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-159933
Filing Date
2017-05-05
Accepted
2017-05-05 09:01:54
Documents
47
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d384007d10q.htm 10-Q 541347
2 EX-31.1 d384007dex311.htm EX-31.1 9550
3 EX-31.2 d384007dex312.htm EX-31.2 9668
4 EX-32.1 d384007dex321.htm EX-32.1 5485
  Complete submission text file 0001193125-17-159933.txt   2217402

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ardx-20170331.xml EX-101.INS 354027
6 XBRL TAXONOMY EXTENSION SCHEMA ardx-20170331.xsd EX-101.SCH 26453
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ardx-20170331_cal.xml EX-101.CAL 44599
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ardx-20170331_def.xml EX-101.DEF 63194
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ardx-20170331_lab.xml EX-101.LAB 195629
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ardx-20170331_pre.xml EX-101.PRE 134094
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36485 | Film No.: 17816315
SIC: 2834 Pharmaceutical Preparations